Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference104 articles.
1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998
2. Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents;Ajjan;Diabetes Vasc Dis Res,2006
3. Type 2 diabetes and atherosclerotic cardiovascular disease: do they share common antecedents?;Krentz;Br J Diabetes Vasc Dis,2002
4. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study;Stratton;BMJ,2000
5. Diabetes UK. Diabetes in the UK 2004, 2004; 1-27.
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP);Science Bulletin;2021-08
2. Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016;Journal of Clinical Medicine;2020-11-06
3. Quantification of Insulin Action in Human Subjects;Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease;2019
4. Thiazolidinediones Cause Cardiotoxicity via PPARγ- Independent Mechanism;Cardiotoxicity;2018-11-14
5. Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients;Journal of Cellular Physiology;2018-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3